Carcinogenesis Advance Access originally published online on October 29, 2005
Carcinogenesis 2006 27(3):610-618; doi:10.1093/carcin/bgi252
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Carcinogenesis vol.27 no.3 © Oxford University Press 2005; all rights reserved.
Polymorphisms in nucleotide excision repair genes and risk of multiple primary melanoma: the Genes Environment and Melanoma Study
Department of Epidemiology, CB #7435, School of Public Health, University of North Carolina, Chapel Hill, NC 27599, USA, 1 Memorial Sloan-Kettering, Cancer Center, New York, NY, USA, 2 University of New Mexico, Albuquerque, NM, USA, 3 University of California, Irvine; CA, USA, 4 University of Sydney, Sydney, New South, Wales, Australia, 5 Cancercare Ontario, Toronto, Ontario, Canada, 6 University of Michigan, Ann Arbor, MI, USA, 7 Centro per la Prevenzione Oncologia, Torino, Piemonte, Italy, 8 British Columbia Cancer Agency, Vancouver, BC, Canada, 9 Royal Children's Hospital, Parkville, Victoria, Australia, 10 University of Pennsylvania, Philadelphia, PA, USA and 11 Women's College Hospital, Toronto, Ontario, Canada
* To whom correspondence should be addressed. Tel: +919 966 7437; Fax: +919 966 2089; Email: millikan{at}email.unc.edu
Polymorphisms in six genes involved in nucleotide excision repair of DNA were examined in a large population-based casecontrol study of melanoma. Genotyping was conducted for 2485 patients with a single primary melanoma (controls) and 1238 patients with second or higher order primary melanomas (cases). Patients were ascertained from nine geographic regions in Australia, Canada, Italy and the United States. Positive associations were observed for XPD 312 Asn/Asn versus Asp/Asp [odds ratio (OR) = 1.5, 95% confidence interval (CI) 1.21.9] and XPD 751 Gln/Gln versus Lys/Lys (OR = 1.4, 95% CI 1.11.7) genotypes and melanoma. The combined XPD Asn (A) 312 + Gln (C) 751 haplotype was significantly more frequent in cases (32%) compared with controls (29%) (P = 0.003) and risk of melanoma increased significantly with one and two copies of the haplotype (ORs 1.2, 95% CI 1.01.4, and 1.6, 95% CI 1.22.0, trend P = 0.002). No significant associations were observed for HR23B codon 249, XPG codon 1104, XPC codon 939, XPF codon 415, XPF nt 2063, ERCC6 codon 1213 or ERCC6 codon 1230. ORs for XPD and XPC genotypes were stronger for melanoma diagnosed at an early age, but tests for interaction were not statistically significant. The results provide further evidence for a role of XPD in the etiology of melanoma.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
R. R. McWilliams, W. R. Bamlet, M. de Andrade, D. N. Rider, J. M. Cunningham, and G. M. Petersen Nucleotide Excision Repair Pathway Polymorphisms and Pancreatic Cancer Risk: Evidence for role of MMS19L Cancer Epidemiol. Biomarkers Prev., April 1, 2009; 18(4): 1295 - 1302. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. McWilliams, W. R. Bamlet, J. M. Cunningham, E. L. Goode, M. de Andrade, L. A. Boardman, and G. M. Petersen Polymorphisms in DNA Repair Genes, Smoking, and Pancreatic Adenocarcinoma Risk Cancer Res., June 15, 2008; 68(12): 4928 - 4935. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yang, J. Gu, X. Lin, H. B. Grossman, Y. Ye, C. P. Dinney, and X. Wu Profiling of Genetic Variations in Inflammation Pathway Genes in Relation to Bladder Cancer Predisposition Clin. Cancer Res., April 1, 2008; 14(7): 2236 - 2244. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Wang, M. R. Spitz, H. Yang, C. Lu, D. J. Stewart, and X. Wu Genetic Variants in Cell Cycle Control Pathway Confer Susceptibility to Lung Cancer Clin. Cancer Res., October 1, 2007; 13(19): 5974 - 5981. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. An, Z. Liu, Z. Hu, G. Li, L.-E Wang, E. M. Sturgis, A. K. El-Naggar, M. R. Spitz, and Q. Wei Potentially Functional Single Nucleotide Polymorphisms in the Core Nucleotide Excision Repair Genes and Risk of Squamous Cell Carcinoma of the Head and Neck Cancer Epidemiol. Biomarkers Prev., August 1, 2007; 16(8): 1633 - 1638. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. E. Thomas, S. N. Edmiston, A. Alexander, R. C. Millikan, P. A. Groben, H. Hao, D. Tolbert, M. Berwick, K. Busam, C. B. Begg, et al. Number of Nevi and Early-Life Ambient UV Exposure Are Associated with BRAF-Mutant Melanoma Cancer Epidemiol. Biomarkers Prev., May 1, 2007; 16(5): 991 - 997. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Povey, F. Darakhshan, K. Robertson, Y. Bisset, M. Mekky, J. Rees, V. Doherty, G. Kavanagh, N. Anderson, H. Campbell, et al. DNA repair gene polymorphisms and genetic predisposition to cutaneous melanoma Carcinogenesis, May 1, 2007; 28(5): 1087 - 1093. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Li, Z. Hu, Z. Liu, L.-E Wang, S. S. Strom, J. E. Gershenwald, J. E. Lee, M. I. Ross, P. F. Mansfield, J. N. Cormier, et al. Polymorphisms in the DNA Repair Genes XPC, XPD, and XPG and Risk of Cutaneous Melanoma: a Case-Control Analysis Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2526 - 2532. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Kanetsky, T. R. Rebbeck, A. J. Hummer, S. Panossian, B. K. Armstrong, A. Kricker, L. D. Marrett, R. C. Millikan, S. B. Gruber, H. A. Culver, et al. Population-based study of natural variation in the melanocortin-1 receptor gene and melanoma. Cancer Res., September 15, 2006; 66(18): 9330 - 9337. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Berwick, I. Orlow, A. J. Hummer, B. K. Armstrong, A. Kricker, L. D. Marrett, R. C. Millikan, S. B. Gruber, H. Anton-Culver, R. Zanetti, et al. The Prevalence of CDKN2A Germ-Line Mutations and Relative Risk for Cutaneous Malignant Melanoma: An International Population-Based Study. Cancer Epidemiol. Biomarkers Prev., August 1, 2006; 15(8): 1520 - 1525. [Abstract] [Full Text] [PDF] |
||||



